Moderna COVID-19 Vaccine in Transplant Patients Study

COVID-19 Vaccine Trials in Phoenix

Aventiv Research is currently participating in ModernaTX’s mRNA-1273 COVID-19 vaccine study at our Phoenix, AZ location. Moderna’s COVID-19 mRNA-1273 Vaccine has received Emergency Use Authorization in adults 18 years old and over from the U.S. Food and Drug Administration (FDA). The effectiveness of the mRNA-1273 study vaccine in people who have received a solid organ transplant is not known which is why we are conducting this research study.

Enroll Now

Moderna COVID-19 Vaccine in Transplant Patients Study

The primary objective of this clinical trial is to evaluate the safety and immunogenicity of Moderna’s mRNA-1273 vaccine for the prevention of COVID-19 in participants who have had a solid organ transplant, kidney or liver.

We are specifically looking for volunteers who are:

• Adults 18 years old and over
• Kidney or liver (single organ) transplant recipients who are at least 6 months after transplantation
• Medically stable for at least 3 months prior to joining the study

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.